A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
BioNTech SE
BioNTech SE
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
MediLink Therapeutics (Suzhou) Co., Ltd.
Molecular Partners AG
Radiopharm Theranostics, Ltd
Beijing Biotech
Shanghai JMT-Bio Inc.
PMV Pharmaceuticals, Inc
NeoImmuneTech
Bristol-Myers Squibb
Monte Rosa Therapeutics, Inc
Neonc Technologies, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tasca Therapeutics
Shanghai Best-Link Bioscience, LLC
AstraZeneca
IDEAYA Biosciences
Jacobio Pharmaceuticals Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
VM Oncology, LLC
GV20 Therapeutics
DualityBio Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
MediLink Therapeutics (Suzhou) Co., Ltd.
Incyte Corporation
G1 Therapeutics, Inc.
Phanes Therapeutics
Incyte Corporation
Marengo Therapeutics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
TransThera Sciences (Nanjing), Inc.
OncoC4, Inc.
Klus Pharma Inc.
Hutchmed
Heronova Pharmaceuticals
BioNTech SE
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Sellas Life Sciences Group
23andMe, Inc.
Mundipharma Research Limited
Salubris Biotherapeutics Inc
Impact Therapeutics, Inc.
NantCell, Inc.
Pfizer
Chipscreen Biosciences, Ltd.
TransThera Sciences (Nanjing), Inc.